ArticleClinical hypertension2025

Transition from parenteral treprostinil to selexipag aiming at hemodynamic targets in pulmonary arterial hypertension.

Yoonsun Won et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.